Program - 2017 - Immunotherapy: a new standard of care in thoracic malignancies?

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

Research Seminars 2017 - Immunotherapy: a new standard of care in thoracic malignancies?

2017 - Immunotherapy: a new standard of care in thoracic malignancies?

From ineffective tumor immune response to immunomodulation in lung cancer

F. Pagés (Paris, France)

Assembly Symposium

Slides

Accompanying documents

How to evaluate the immune response in the tissue?

M. Tsao (Toronto, Canada)

Slides

Accompanying documents

Unresolved issues in the use of check-point inhibitors in NSCLC

F. Shepherd (Toronto, Canada)

Slides

Check point inhibitors in advanced non small cell cancer

M. Garassino (Milano, Italy)

Slides

Is there a place for ICI in the context of oncogenic addiction?

J. Cadranel (Paris, France)

Slides

Accompanying documents

Vaccination in non small lung cancer

J.G.J.V. Aerts (Breda, Netherlands)

Slides

Accompanying documents

Check point inhibitors in peri-operative non small cell lung cancer strategy

J. Mazieres (Toulouse, France)

Slides

Accompanying documents

Current clinical trials

T. Berghmans (Brussels, Belgium)

Slides

Accompanying documents